Sitesinformation.com

Keyword Analysis & Research: mainz biomed


Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
mainz biomed1.340.938581912
mainz1.20.71547895
biomed0.670.7214466

Keyword Research: People who searched mainz biomed also searched

Keyword CPC PCC Volume Score
mainz biomed1.310.78492100
mainz biomed aktie1.390.220885
mainz biomed news0.260.3670639
mainz biomed aktie forum1.910.2423178
mainz biomed forum1.160.949684
mainz biomed stock1.940.56150100
mainz biomed aktie onvista0.820.7873466
mainz biomed quartalszahlen1.840.74563100
mainz biomed investor relations1.480.2837989
mainz biomed aktienkurs0.970.2128144
mainz biomed n.v0.870.6689429
mainz biomed product lines1.390.1205828
mainz biomed stock price0.310.72630100
mainz biomed share price1.010.6469941
uni mainz biomedizin0.270.5604694

Search Results related to mainz biomed on Search Engine

  • Home - Mainz Biomed

    mainzbiomed.com

    https://mainzbiomed.com/

    WEBApr 9, 2024 · To be effective, cancer detection needs to be simple, readily available, and affordable. We develop innovative products that quickly and reliably identify the early onset of several leading deadly conditions – such as colorectal (“CRC”) and pancreatic cancer. Our goal is to place effective solutions where they need to be….

    DA: 11 PA: 79 MOZ Rank: 49 Up or Down: Up

  • Our Company - Mainz Biomed

    mainzbiomed.com

    https://mainzbiomed.com/our-company/

    WEBMainz BioMed ( NASDAQ: MYNZ) develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. Mainz, Germany. Mainz Biomed ( NASDAQ: MYNZ) is located just west of Frankfurt in a world-renowned community for advanced DNA & Pharmaceutical research, including the home of vaccine maker BioNTech SE.

    DA: 86 PA: 82 MOZ Rank: 85 Up or Down: Up

  • News - Mainz Biomed

    mainzbiomed.com

    https://mainzbiomed.com/news/

    WEBApr 9, 2024 · Mainz Biomed Reports Full Year 2023 Financial Results. April 9, 2024. Read More. Written by. Mainz Biomed. Corporate News. Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment. March 19, 2024.

    DA: 52 PA: 34 MOZ Rank: 32 Up or Down: Up

  • Mainz Biomed Reports Full Year 2023 Financial Results - Yahoo …

    yahoo.com

    https://finance.yahoo.com/news/mainz-biomed-reports-full-2023-120100285.html

    WEBApr 9, 2024 · BERKELEY, Calif. and MAINZ, Germany, April 09, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a leader in molecular genetics diagnostic ...

    DA: 1 PA: 36 MOZ Rank: 29 Up or Down: Up

  • Mainz Biomed N.V. (MYNZ) Stock Price, News, Quote & History - Yahoo Finance

    yahoo.com

    https://finance.yahoo.com/quote/MYNZ

    WEBFind the latest Mainz Biomed N.V. (MYNZ) stock quote, history, news and other vital information to help you with your stock trading and investing.

    DA: 54 PA: 22 MOZ Rank: 87 Up or Down: Up

  • Mainz Biomed’s ColoFuture Study, Evaluating its Novel mRNA

    globenewswire.com

    https://www.globenewswire.com/news-release/2023/09/13/2742195/0/en/Mainz-Biomed-s-ColoFuture-Study-Evaluating-its-Novel-mRNA-Biomarkers-Reports-Groundbreaking-Topline-Results-Demonstrating-Sensitivity-for-Colorectal-Cancer-of-94-with-Specificity-o.html

    WEBSep 13, 2023 · BERKELEY, Calif. and MAINZ, Germany, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company...

    DA: 19 PA: 47 MOZ Rank: 44 Up or Down: Up

  • Mainz Biomed Reports Positive Topline Results from U.S. eAArly …

    yahoo.com

    https://finance.yahoo.com/news/mainz-biomed-reports-positive-topline-140100520.html

    WEBDecember 5, 2023 · 7 min read. Mainz BioMed NV. Groundbreaking Results Demonstrate Sensitivity for Colorectal Cancer of 97% with Specificity of 97% and Advanced Adenoma Sensitivity of 82%...

    DA: 53 PA: 58 MOZ Rank: 29 Up or Down: Up

  • Mainz Biomed | LinkedIn

    linkedin.com

    https://www.linkedin.com/company/mainz-biomed

    WEBAbout us. Mainz Biomed is aiming to become a leading provider of easy-to-use diagnostic solutions for patients everywhere. We develop innovative products that quickly and easily identify the...

    DA: 84 PA: 98 MOZ Rank: 36 Up or Down: Up

  • Mainz Biomed N.V. Announces Pricing of Initial Public

    globenewswire.com

    https://www.globenewswire.com/news-release/2021/11/04/2328142/0/en/Mainz-Biomed-N-V-Announces-Pricing-of-Initial-Public-Offering.html

    WEBNov 4, 2021 · BERKELEY, Calif. and MAINZ, Germany, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostics company...

    DA: 70 PA: 46 MOZ Rank: 78 Up or Down: Up

  • Mainz Biomed NV (MYNZ) Stock Price & News - Google Finance

    google.com

    https://www.google.com/finance/quote/MYNZ:NASDAQ

    WEBMainz Biomed NV. Share. $0.99. After Hours: $1.05. (6.05%) +0.060. Closed: Apr 9, 5:20:00 PM GMT-4 · USD · NASDAQ · Disclaimer. 1D. 5D. 1M. 6M. YTD. 1Y. 5Y. MAX. search Compare to. Heart Test...

    DA: 84 PA: 14 MOZ Rank: 99 Up or Down: Up